In summary, our study involved constructing patient-specific iPSCs carrying the AIFM1 c.1265 G > A variant and their gene-corrected isogenic models, and revealed that the AIFM1 variant is one of the molecular bases of ANSD. The gene discussed is AIFM1; the disease is auditory neuropathy.